| Unknown | Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia | Phase 1 | 2022-10-01 |
| Withdrawn | Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid T Advanced Solid Tumor | Phase 1 | 2021-08-11 |
| Unknown | A Phase I Open-label Study for Subjects With Advanced Malignancies Advanced Solid Malignancies | Phase 1 | 2021-04-21 |
| Terminated | The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol Solid Tumor, Adult | Phase 1 | 2019-08-05 |
| Completed | A PK Study of Oraxol in Breast Cancer Patients Breastcancer | Phase 1 | 2019-04-22 |
| Completed | A Study of Oraxol in Subjects With Cutaneous Angiosarcoma Angiosarcoma of Skin | Phase 2 | 2018-12-21 |
| Terminated | Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors Solid Tumor | Phase 1 | 2018-10-25 |
| Completed | Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scal Actinic Keratoses | Phase 1 | 2018-09-07 |
| Completed | Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies Solid Tumor | Phase 1 | 2018-07-19 |
| Terminated | An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007 Breastcancer | Phase 1 | 2017-10-25 |
| Unknown | A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Mali Solid Tumor | Phase 1 | 2017-04-20 |
| Unknown | Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal Cancers Gastric Cancer, Esophageal Cancer, Gastro-esophageal Cancer | Phase 1 | 2016-12-08 |
| Completed | A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies Solid Tumor | Phase 1 | 2016-03-01 |
| Completed | Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Can Metastatic Breast Cancer | Phase 3 | 2015-12-02 |
| Completed | A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients Solid Tumor | Phase 2 | 2015-09-23 |
| Completed | A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel Solid Tumor | Phase 1 | 2015-08-01 |
| Completed | Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Kerat Actinic Keratosis | Phase 1 | 2014-12-01 |
| Completed | Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies Advance Malignancies | Phase 1 | 2014-12-01 |
| Completed | A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Su Solid Tumor | Phase 1 | 2014-09-05 |
| Completed | Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer Bone-Metastatic, Castration-Resistant Prostate Cancer | Phase 2 | 2010-02-01 |
| Completed | Evaluation of KX2-391 in Patients With Advanced Malignancies Solid Tumors, Lymphoma | Phase 1 | 2007-11-01 |